Affinity-based proteomic profiling: Problems and achievements

Proteomics

Volumn 12, Issue 4-5, 2012, Pages 621-637

  Medvedev, Alexei ^a   Kopylov, Arthur ^a   Buneeva, Olga ^a   Zgoda, Victor ^a   Archakov, Alexander ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Affinity chromatography; Affinity ligands; Cell biology; Chemical proteomics; Pharmacoproteomics; Subproteome isolation

Indexed keywords

CONCANAVALIN A; CYCLIC AMP; CYCLIC GMP; GLYCOPROTEIN; HYDROXYAPATITE; ISATIN; PHOSPHOPROTEIN; PROTEIN KINASE; UBIQUITIN; UBIQUITINATED PROTEIN; WHEAT GERM AGGLUTININ;

AFFINITY CHROMATOGRAPHY; BINDING AFFINITY; IMMUNOAFFINITY CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; PROTEOMICS; RADIATION DOSE FRACTIONATION; REVIEW; SIGNAL TRANSDUCTION;

CELL FRACTIONATION; CHEMICAL FRACTIONATION; CHROMATOGRAPHY, AFFINITY; GENE EXPRESSION PROFILING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEINS; PROTEOMICS;

EID: 84859219643     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100373     Document Type: Review

References (182)

1. Gilar, M., Bouvier, E. S., Compton, B. J., Advances in sample preparation in electromigration, chromatographic and mass spectrometric separation methods. J. Chromatogr. A 2001, 909, 111-135.
2. Lee, W. C., Lee, K. H., Applications of affinity chromatography in proteomics. Anal. Biochem. 2004, 324, 1-10.
3. Pernemalm, M., Lewensohn, R., Lehtio, J., Affinity prefractionation for MS-based plasma proteomics. Proteomics 2009, 9, 1420-1427.
4. Ly, L., Wasinger, V. C., Protein and peptide fractionation, enrichment and depletion: Tools for the complex proteome. Proteomics. 2011, 11, 513-534.
5. Rigaut, G., Shevchenko, A., Rutz, B., Wilm, M. et al., A generic protein purification method for protein complex characterization and proteome exploration. Nat. Biotechnol. 1999, 17, 1030-1032.
6. Collins, S. R., Miller, K. M., Maas, N. L., Roguev, A. et al., Functional dissection of protein complexes involved in yeast chromosome biology using a genetic interaction map. Nature 2007, 446, 806-810.
7. Uhlén, M., Affinity as a tool in life science. Biotechniques 2008, 44, 649-654.
8. Takase, T., Rotblat, F., Goodall, A. H., Kernoff, P. B. et al., Production of factor VIII deficient plasma by immunodepletion using three monoclonal antibodies. Br. J. Haematol. 1987, 66, 497-502.
9. Pieper, R., Su, Q., Gatlin, C. L., Huang, S. T. et al., Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome. Proteomics 2003, 3, 422-432.
10. Steinsträßer, L., Jacobsen, F., Hirsch, T., Kesting, M. et al., Immunodepletion of high-abundant proteins from acute and chronic wound fluids to elucidate low-abundant regulators in wound healing. BMC Res. Notes 2010, 3, 335.
11. Bandow, J. E., Comparison of protein enrichment strategies for proteome analysis of plasma. Proteomics 2010, 10, 1416-1425.
12. Brand, J., Haslberger, T., Zolg, W., Pestlin, G., Palme, S., Depletion efficiency and recovery of trace markers from a multiparameter immunodepletion column. Proteomics 2006, 6, 3236-3242.
13. Echan, L. A., Tang, H. Y., Ali-Khan, N., Lee, K., Speicher, D.W., Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma. Proteomics 2005, 5, 3292-3303.
14. Yocum, A. K., Yu, K., Oe, T., Blair, I. A., Effect of immunoaffinity depletion of human serum during proteomic investigations. J. Proteome Res. 2005, 4, 1722-1731.
15. Zolotarjova, N., Martosella, J., Nicol, G., Bailey, J. et al., Differences among techniques for high-abundant protein depletion. Proteomics 2005, 5, 3304-3313.
16. Gong, Y., Li, X., Yang, B., Ying, W. et al., Different immunoaffinity fractionation strategies to characterize the human plasma proteome. J. Proteome Res. 2006, 5, 1379-1387.
17. Niwa, T., Biomarker discovery for kidney diseases by mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2008, 870, 148-153.
18. Yu, K. H., Rustgi, A. K., Blair, I. A., Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. J. Proteome Res. 2005, 4, 1742-1751.
19. Martosella, J., Zolotarjova, N., Liu, H., Nicol, G., Boyes, B. E., Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins. J. Proteome Res. 2005, 4, 1522-1537.
20. Mortezai, N., Harder, S., Schnabel, C., Moors, E. et al., Tandem affinity depletion: a combination of affinity fractionation and immunoaffinity depletion allows the detection of low-abundance components in the complex proteomes of body fluids. J. Proteome Res. 2010, 9, 6126-6134.
21. Qian, W. J., Jacobs, J. M., Liu, T., Camp, D. G., 2nd, Smith, R. D., Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications. Mol. Cell. Proteomics 2006, 5, 1727-1744.
22. Jmeian, Y., El Rassi, Z., Liquid-phase-based separation systems for depletion, prefractionation and enrichment of proteins in biological fluids for in-depth proteomics analysis. Electrophoresis 2009, 30, 249-261.
23. Pernemalm, M., Lewensohn, R., Lehtiö, J., Affinity prefractionation for MS-based plasma proteomics. Proteomics 2009, 9, 1420-1427.
24. Scholten, A., Poh, M. K., van Veen, T. A., van Breukelen, B. et al., Analysis of the cGMP/cAMP interactome using a chemical proteomics approach in mammalian heart tissue validates sphingosine kinase type 1-interacting protein as a genuine and highly abundant AKAP. J. Proteome Res. 2006, 5, 1435-1447.
25. Aye, T. T., Mohammed, Sh., van den Toorn, H. W. P., van Veen, T. A. B. et al., Selectivity in enrichment of cAMP-dependent protein kinase regulatory subunits type I and type II and their interactors using modified cAMP affinity resins. Mol. Cell. Proteomics 2009, 8, 1016-1028.
26. Bertinetti, D., Schweinsberg, S., Hanke, S. E., Schwede, F. et al., Chemical tools selectively target components of the PKA system. BMC Chem. Biol. 2009, 9, 3. DOI: 10.1186/1472-6769-9-3.
27. Bender, A. T., Beavo, J. A., Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use. Pharmacol. Rev. 2006, 58, 488-520.
28. Dadvar, P., O'Flaherty, M., Scholten, A., Rumpel, K., Heck, A. J. R., A chemical proteomics based enrichment technique targeting the interactome of the PDE5 inhibitor PF-4540124w. Mol. BioSyst. 2009, 5, 472-482.
29. Raijmakers, R., Dadvar, P., Pelletier, S., Gouw, J. et al., Target profiling of a small library of phosphodiesterase 5 (PDE5) inhibitors using chemical proteomics. ChemMedChem. 2010, 5, 1927-1936.
30. Wissing, J., Godl, K., Brehmer, D., Blencke, S. et al., Chemical proteomic analysis reveals alternative modes of action for pyrido[2, 3-d]pyrimidine kinase inhibitors. Mol. Cell. Proteomics 2004, 3, 1181-1193.
31. Oppermann, F. S., Gnad, F., Olsen, J. V., Hornberger, R. et al., Large-scale proteomics analysis of the human kinome. Mol. Cell. Proteomics 2009, 8, 1751-1764.
32. Godl, K., Wissing, J., Kurtenbach, A., Habenberger, P. et al., An efficient proteomics method to identify the cellular targets of protein kinase inhibitors. Proc. Natl. Acad. Sci. USA 2003, 100, 15434-15439.
33. Bain, J., McLauchlan, H., Elliott, M., Cohen, P., The specificities of protein kinase inhibitors: an update. Biochem. J. 2003, 371, 199-204.
34. Bain, J., Plater, L., Elliott, M., Shpiro, N. et al., The selectivity of protein kinase inhibitors: a further update. Biochem. J. 2007, 408, 297-315.
35. Davies, S. P., Reddy, H., Caivano, M., Cohen, P., Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 2000, 351, 95-105.
36. Manning, G., Whyte, D. B., Martinez, R., Hunter, T., Sudarsanam, S., The protein kinase complement of the human genome. Science 2002, 298, 1912-1934.
37. Wissing, J., Godl, K., Brehmer, D., Blencke, S. et al., Chemical proteomic analysis reveals alternative modes of action for pyrido[2, 3-d]pyrimidine kinase inhibitors. Mol. Cell. Proteomics 2004, 3, 1181-1193.
38. Wissing, J., Jansch, L., Nimtz, M., Dieterich, G. et al., Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry. Mol. Cell. Proteomics 2007, 6, 537-547.
39. Tokumitsu, H., Hatano, N., Inuzuka, H., Sueyoshi, Y. et al., Phosphorylation of Numb family proteins. Possible involvement of Ca2+/calmodulin-dependent protein kinases. J. Biol. Chem. 2005, 280, 35108-35118.
40. Reinders, J., Sickmann, A., State-of-the-art in phosphoproteomics. Proteomics 2005, 5, 4052-4061.
41. Zhang, H., Zha, X., Tan, Y., Hornbeck, P.V., Phosphoprotein analysis using antibodies broadly reactive against phosphorylated motifs. J. Biol. Chem. 2002, 277, 39379-39387.
42. Thingholm, T. E., Jensen, O. N., Larsen, M. R., Analytical strategies for phosphoproteomics. Proteomics 2009, 9, 1451-1468.
43. Li, S., Dass, C., Iron(III)-immobilized metal ion affinity chromatography and mass spectrometry for the purification and characterization of synthetic phosphopeptides. Anal. Biochem. 1999, 270, 9-14.
44. Posewitz, M. C., Tempst, P., Immobilized gallium(III) affinity chromatography of phosphopeptides. Anal. Chem. 1999, 71, 2883-2892.
45. Nuhse, T. S., Stensballe, A., Jensen, O. N., Peck, S. C., Large-scale analysis of in vivo phosphorylated membrane proteins by immobilized metal ion affinity chromatography and mass spectrometry. Mol. Cell. Proteomics 2003, 2, 1234-1243.
46. Nuhse, T. S., Bottrill, A. R., Jones, A. M., Peck, S. C., Quantitative phosphoproteomic analysis of plasma membrane proteins reveals regulatory mechanisms of plant innate immune responses. Plant J. 2007, 51, 931-940.
47. Gruhler, A., Olsen, J. V., Mohammed, S., Mortensen, P. et al., Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway. Mol. Cell. Proteomics 2005, 4, 310-327.
48. Saha, A., Saha, N., Ji, L. N., Zhao, J. et al., Stability of metal ion complexes formed with methyl phosphate and hydrogen phosphate. J. Biol. Inorg. Chem. 1996, 1, 231-238.
49. D'Ambrosio, C., Arena, S., Fulcoli, G., Scheinfeld, M. H. et al., Hyperphosphorylation of JNK-interacting protein 1, a protein associated with Alzheimer disease. Mol. Cell. Proteomics 2006, 5, 97-113.
50. McNulty, D. E., Annan, R. S., Hydrophilic interaction chromatography reduces the complexity of the phosphoproteome and improves global phosphopeptide isolation and detection. Mol. Cell. Proteomics 2008, 7, 971-980.
51. Stone, M. D., Chen, X., McGowan, T., Bandhakavi, S. et al., Large-scale phosphoproteomics analysis of whole saliva reveals a distinct phosphorylation pattern. J. Proteome Res. 2011, 10, 1728-1736.
52. Ficarro, S. B., McCleland, M. L., Stukenberg, P. T., Burke, D. J. et al., Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat. Biotechnol. 2002, 20, 301-305.
53. Yang, F., Waters, K. M., Miller, J. H., Gritsenko, M. A. et al., Phosphoproteomics profiling of human skin fibroblast cells reveals pathways and proteins affected by low doses of ionizing radiation. PLoS One 2010, 5, e14152.
54. Larsen, M. R., Thingholm, T. E., Jensen, O. N., Roepstorff, P., Jorgensen, T. J., Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Mol. Cell. Proteomics 2005, 4, 873-886.
55. Jensen, S. S., Larsen, M. R., Evaluation of the impact of some experimental procedures on different phosphopeptide enrichment techniques. Rapid Comm. Mass Spectrom. 2007, 21, 3635-3645.
56. Thingholm, T. E., Jorgensen, T. J., Jensen, O. N., Larsen, M. R., Highly selective enrichment of phosphorylated peptides using titanium dioxide. Nat. Protoc. 2006, 1, 1929-1935.
57. Thingholm, T. E., Larsen, M. R., Ingrell, C. R., Kassem, M., Jensen, O. N., TiO(2)-based phosphoproteomic analysis of the plasma membrane and the effects of phosphatase inhibitor treatment. J. Proteome Res. 2008, 7, 3304-3313.
58. Bodenmiller, B., Mueller, L. N., Mueller, M., Domon, B., Aebersold, R., Reproducible isolation of distinct, overlapping segments of the phosphoproteome. Nat. Methods 2007, 4, 231-237.
59. Mann, K., Olsen, J. V., Macek, B., Gnad, F., Mann, M., Phosphoproteins of the chicken eggshell calcified layer. Proteomics 2007, 7, 106-115.
60. Molina, H., Horn, D. M., Tang, N., Mathivanan, S., Pandey, A., Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry. Proc. Natl. Acad. Sci. USA 2007, 104, 2199-2204.
61. Olsen, J. V., Blagoev, B., Gnad, F., Macek, B., Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006, 127, 635-648.
62. 2-based phosphoproteomics applied to study endogenous phosphorylation in Drosophila melanogaster. J. Proteome Res. 2008, 7, 687-697.
63. Schuchardt, S., Borlak, J., Quantitative mass spectrometry to investigate epidermal growth factor receptor phosphorylation dynamics. Mass Spectrom. Rev. 2008, 27, 51-65.
64. Reiland, S., Messerli, G., Baerenfaller, K., Gerrits, B. et al., Large-scale Arabidopsis phosphoproteome profiling reveals novel chloroplast kinase substrates and phosphorylation networks. Plant Physiol. 2009, 150, 889-903.
65. Kota, U., Chien, K. Y., Goshe, M. B., Isotope-labeling and affinity enrichment of phosphopeptides for proteomic analysis using liquid chromatography-tandem mass spectrometry. Methods Mol Biol. 2009, 564, 303-321.
66. Thingholm, T. E., Jensen, O. N., Enrichment and characterization of phosphopeptides by immobilized metal affinity chromatography (IMAC) and mass spectrometry. Methods Mol Biol. 2009a, 527, 47-56, xi.
67. Cao, P., Stults, J. T., Phosphopeptide analysis by on-line immobilized metal-ion affinity chromatography-capillary electrophoresis-electrospray ionization mass spectrometry. J. Chromatogr. A 1999, 853, 225-235.
68. Li, Y., Leng, T., Lin, H., Deng, C. et al., Preparation of Fe3O4@ZrO2 core-shell microspheres as affinity probes for selective enrichment and direct determination of phosphopeptides using matrix-assisted laser desorption ionization mass spectrometry. J. Proteome Res. 2007, 6, 4498-4510.
69. Zhou, H., Tian, R., Ye, M., Xu, S. et al., Highly specific enrichment of phosphopeptides by zirconium dioxide nanoparticles for phosphoproteome analysis. Electrophoresis 2007, 28, 2201-2215.
70. Aryal, U. K., Ross, A. R., Enrichment and analysis of phosphopeptides under different experimental conditions using titanium dioxide affinity chromatography and mass spectrometry. Rapid Commun. Mass Spectrom. 2010, 24, 219-231.
71. Thingholm, T. E., Jensen, O. N., Robinson, P. J., Larsen, M. R., SIMAC (sequential elution from IMAC), a phosphoproteomics strategy for the rapid separation of monophosphorylated from multiply phosphorylated peptides. Mol. Cell. Proteomics 2008a, 7, 661-671.
72. Thingholm, T. E., Jensen, O. N., Larsen, M. R., Enrichment and separation of mono- and multiply phosphorylated peptides using sequential elution from IMAC prior to mass spectrometric analysis. Methods Mol. Biol. 2009b, 527, 67-78.
73. Mamone, G., Picariello, G., Ferranti, P., Addeo, F., Hydroxyapatite affinity chromatography for the highly selective enrichment of mono- and multi-phosphorylated peptides in phosphoproteome analysis. Proteomics 2010, 10, 380-393.
74. Gronborg, M., Kristiansen, T. Z., Stensballe, A., Andersen, J. S., A mass spectrometry-based proteomic approach for identification of serine/threonine-phosphorylated proteins by enrichment with phospho-specific antibodies: identification of a novel protein, Frigg, as a protein kinase A substrate. Mol. Cell. Proteomics 2002, 1, 517-527.
75. Collins, M. O., Yu, L., Choudhary, J. S., Analysis of protein phosphorylation on a proteome-scale. Proteomics 2007, 7, 2751-2768.
76. Ficarro, S., Chertihin, O., Westbrook, V. A., White, F., Phosphoproteome analysis of capacitated human sperm. Evidence of tyrosine phosphorylation of a kinase-anchoring protein 3 and valosin-containing protein/p97 during capacitation. J. Biol. Chem. 2003, 278, 11579-11589.
77. Zheng, H., Hu, P., Quinn, D. F., Wang, Y. K., Phosphotyrosine proteomic study of interferon alpha signaling pathway using a combination of immunoprecipitation and immobilized metal affinity chromatography. Mol. Cell. Proteomics 2005, 4, 721-730.
78. Rush, J., Moritz, A., Lee, K. A., Guo, A., Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 2005, 23, 94-101.
79. Steen, H., Kuster, B., Fernandez, M., Pandey, A., Mann, M., Tyrosine phosphorylation mapping of the epidermal growth factor receptor signaling pathway. J. Biol. Chem. 2002, 277, 1031-1039.
80. Colpitts, T. M., Cox, J., Nguyen, A., Feitosa, F. et al., Use of a tandem affinity purification assay to detect interactions between West Nile and dengue viral proteins and proteins of the mosquito vector. Virology 2011, 417, 179-187.
81. Daulat, A. M., Maurice, P., Jockers, R., Tandem affinity purification and identification of GPCR-associated protein complexes. Methods Mol Biol. 2011, 746, 399-409.
82. Liu, W., Iliuk, A., Tao, A., Ding, S., Identifying protein complexes by affinity purification and mass spectrometry analysis in the rice blast fungus. Methods Mol Biol. 2011, 722, 157-166.
83. Günzl, A., Schimanski, B., Tandem affinity purification of proteins. Curr. Protoc. Protein Sci. 2009, 55, 19.19.1-19.19.16.
84. Angrand, P. O., Segura, I., Völkel, P., Ghidelli, S. et al., Transgenic mouse proteomics identifies new 14-3-3-associated proteins involved in cytoskeletal rearrangements and cell signaling. Mol. Cell. Proteomics 2006, 5, 2211-2227.
85. Oda, Y., Nagasu, T., Chait, B.T., Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome. Nat. Biotechnol. 2001, 19, 379-382.
86. Goshe, M. B., Veenstra, T. D., Panisko, E. A., Conrads, T. P. et al., Phosphoprotein isotope-coded affinity tags: application to the enrichment and identification of low-abundance phosphoproteins. Anal. Chem. 2002, 74, 607-616.
87. Wisniewski, J. R., Tools for phospho- and glycoproteomics of plasma membranes. Amino Acids 2010, 41, 223-233.
88. Wells, L., Vosseller, K., Hart, G. W., Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science 2001, 291, 2376-2378.
89. Hofsteenge, J., Muller, D. R., Debeer, T., New-type of linkage between a carbohydrate and a protein C-glycosylation of a specific tryptophan residue in human. RNase Us. Biochemistry 1994, 33, 13524-13530.
90. Lee, A., Nakano, M., Hincapie, M., Kolarich, D. et al., The lectin riddle: glycoproteins fractionated from complex mixtures have similar glycomic profiles. J. Integr. Biol. 2010, 14, 487-499.
91. Drake, R. R., Schwegler, E. E., Malik, G., Diaz, J. et al., Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers. Mol. Cell. Proteomics 2006, 5, 1957-1967.
92. Dam, T. K., Roy, R., Das, S. K., Oscarson, S., Brewer, C. F., Binding of multivalent carbohydrates to concanavalin A and Diocleagrandiflora lectin: thermodynamic analysis of the "multivalency effect". J. Biol. Chem. 2000, 275, 14223-14230.
93. Goldstein, I. J., Studies on the combining sites of concanavalin A. Adv. Exp. Med. Biol. 1975, 55, 35-53.
94. Brewer, C. F., Bhattacharyya, L., Specificity of concanavalin A binding to asparagine-linked glycopeptides. A nuclear magnetic relaxation dispersion study. J. Biol. Chem. 1986, 261, 7306-7310.
95. Cummings, R. D., Kornfeld, S., Fractionation of asparagine-linked oligosaccharides by serial lectin-Agarose affinity chromatography. A rapid, sensitive, and specific technique. J. Biol. Chem. 1982, 257, 11235-11240.
96. Young, N. M., Johnston, R. A., Watson, D.C., The amino acid sequences of jacalin and the Maclura pomifera agglutinin. FEBS Lett. 1991, 282, 382-384.
97. Bourne, Y., Astoul, C. H., Zamboni, V., Peumans, W. J. et al., Structural basis for the unusual carbohydrate-binding specificity of jacalin towards galactose and mannose. Biochem. J. 2002, 364, 173-180.
98. Roque-Barreira, M. C., Campos-Neto, A., Jacalin: An IgA-binding lectin. J. Immunol. 1985, 134, 1740-1743.
99. Do, S. I., Lee, K. Y., Jacalin interacts with Asn-linked glycopeptides containing multi-antennary oligosaccharide structure with terminal alpha-linked galactose. FEBS Lett. 1998, 421, 169-173.
100. Nagata, Y., Burger, M. M., Wheat germ agglutinin. Molecular characteristics and specificity for sugar binding. J. Biol. Chem. 1974, 249, 3116-3122.
101. Iskratsch, T., Braun, A., Paschinger, K., Wilson, I. B., Specificity analysis of lectins and antibodies using remodeled glycoproteins. Anal. Biochem. 2009, 386, 133-146.
102. Yang, Z., Harris, L. E., Palmer-Toy, D. E., Hancock, W. S., Multilectin affinity chromatography for characterization of multiple glycoprotein biomarker candidates in serum from breast cancer patients. Clin. Chem. 2006, 52, 1897-1905.
103. Zhang, H., Li, X. J., Martin, D. B., Aebersold, R., Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 2003, 21, 660-666.
104. Wollscheid, B., Bausch-Fluck, D., Henderson, C., O'Brien, R. et al., Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Nat. Biotechnol. 2009, 27, 378-386.
105. Hedlund, M., Ng, E., Varki, A., Varki, N. M., 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo. Cancer Res. 2008, 68, 388-394.
106. Roth, J., Cellular sialoglycoconjugates: a histochemical perspective. Histochem. J. 1993, 25, 687-710.
107. McDonald, C. A., Yang, J. Y., Marathe, V., Yen, T. Y., Macher, B. A., Combining results from lectin affinity chromatography and glycocapture approaches substantially improves the coverage of the glycoproteome. Mol. Cell. Proteomics 2009, 8, 287-301.
108. Wang, W. C., Cummings, R. D., The immobilized leukoagglutinin from the seeds of Maackia amurensis binds with high affinity to complextype Asn-linked oligosaccharides containing terminal sialic acid-linked d-2, 3 to penultimate galactose residues. J. Biol. Chem. 1988, 263, 4576-4585.
109. Imberty, A., Gautier, C., Lescar, J., Perez, S. et al., An unusual carbohydrate binding site revealed by the structures of two Maackia amurensis lectins complexed with sialic acid-containing oligosaccharides. J. Biol. Chem. 2000, 275, 17541-17548.
110. Wells, L., Vosseller, K., Cole, R. N., Cronshaw, J. M. et al., Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications. Mol. Cell. Proteomics 2002, 1, 791-804.
111. Chalkley, R. J., Burlingame, A. L., Identification of GlcNAcylation sites of peptides and α-crystallin using Q-TOF mass spectrometry. J. Am. Soc. Mass Spectrom. 2001, 12, 1106-1113.
112. Greis, K. D., Hayes, B. K., Comer, F. I., Kirk, M. et al., Selective detection and site-analysis of O-Glc-NAc-modified glycopeptides by beta-elimination and tandem electrospray mass spectrometry. Anal. Biochem. 1996, 234, 38-49.
113. Haynes, P. A., Aebersold, R., Simultaneous detection and identification of O-GlcNAc-modified glycoproteins using liquid chromatography-tandem mass spectrometry. Anal. Chem. 2000, 72, 5402-5410.
114. Mann, M., Ong, S. E., Gronborg, M., Steen, H. et al., Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. Trends Biotechnol. 2002, 20, 261-268.
115. Loughrey Chen, S., Huddleston, M. J., Shou, W., Deshaies, R. J. et al., Mass spectrometry-based methods for phosphorylation site mapping of hyperphosphorylated proteins applied to Net1, a regulator of exit from mitosis in yeast. Mol. Cell. Proteomics 2002, 1, 186-196.
116. Conrads, T. P., Issaq, H. J., Veenstra, T. D., New tools for quantitative phosphoproteome analysis. Biochem. Biophys. Res. Commun. 2002, 290, 885-890.
117. Dehennaut, V., Slomianny, M. C., Page, A., Vercoutter-Edouart, A. S. et al., Identification of structural and functional O-linked N-acetylglucosamine-bearing proteins in Xenopus laevis oocyte. Mol. Cell. Proteomics 2008, 7, 2229-2245.
118. Olajos, M., Szekrényes, á., Hajos, P., Gjerde, D. T., Guttman, A., Boronic acid lectin affinity chromatography (BLAC). 3. Temperature dependence of glycoprotein isolation and enrichment. Anal. Bioanal. Chem. 2010, 397, 2401-2407.
119. Monzo, A., Bonn, G. K., Guttman, A., Boronic acid-lectin affinity chromatography. 1. Simultaneous glycoprotein binding with selective or combined elution. Anal. Bioanal. Chem. 2007, 389, 2097-2102.
120. Zhang, Q., Schepmoes, A. A., Brock, J. W. C., Wu, S. et al., Improved methods for the enrichment and analysis of glycated peptides. Anal. Chem. 2008, 24, 9822-9829.
121. Jin, S., Zhu, C., Cheng, Y., Li, M., Wang, B., Synthesis and carbohydrate binding studies of fluorescent α-amidoboronic acids and the corresponding bisboronic acids. Bioorg. Med. Chem. 2010a, 4, 1449-1455.
122. Yan, J., Fang, H., Wang, B., Boronolectins and fluorescent boronolectins: an examination of the detailed chemistry issues important for the design. Med. Res. Rev. 2005, 5, 490-520.
123. Cao, H., Heagy, M. D., Fluorescent chemosensors for carbohydrates: a decade's worth of bright spies for saccharides in review. J. Fluoresc. 2004, 5, 569-584.
124. Jin, S., Zhu, C., Li, M., Wang, B., Identification of the First fluorescent α-amidoboronic acids that change fluorescent properties upon sugar binding. Bioorg. Med. Chem. Lett. 2009, 6, 1596-1599.
125. Singhal, R. P., Ramamurthy, B., Govindraj, N., Sarwar, Y., New ligands for boronate affinity chromatography: synthesis and properties. J. Chromatogr. 1991, 543, 17-38.
126. Gardiner, S. J., Smith, B. D., Duggan, P. J., Karpa, M. J., Griffin, G. J., Selective fructose transport through supported liquid membranes containing diboronic acid or conjugated monoboronic acid-quaternary ammonium carriers. Tetrahedron 1999, 55, 2857-2864.
127. Matteson, D. S., Functional group compatibilities in boronic ester chemistry. J. Organomet. Chem. 1999, 581, 51-65.
128. Sparbier, K., Asperger, A., Resemann, A., Kessler, I. et al., Analysis of glycoproteins in human serum by means of glycospecific magnetic bead separation and LC-MALDI-TOF/TOF analysis with automated glycopeptide detection. J. Biomol. Tech. 2007, 18, 252-258.
129. Sparbier, K., Koch, S., Kessler, I., Wenzel, T., Kostrzewa, M., Selective isolation of glycoproteins and glycopeptides for MALDI-TOF MS detection supported by magnetic particles. J. Biomol. Techn. 2005, 16, 407-413.
130. Little, R. R., Vesper, H., Rohlfing, C. L., Ospina, M. et al., Validation by a mass spectrometric reference method of use of boronate affinity chromatography to measure glycohemoglobin in the presence of hemoglobin S and C Traits. Clin. Chem. 2005, 51, 264-265.
131. Priego-Capote, F., Scherl, A., Müller, M., Waridel, P. et al., Glycation isotopic labeling with 13C-reducing sugars for quantitative analysis of glycated proteins in human plasma. Mol. Cell. Proteomics 2010, 3, 579-592.
132. Choi, Y. G., Lim, S., Characterization of anti-advanced glycation end product antibodies to nonenzymatically lysine-derived and arginine-derived glycated products. J. Immunoassay Immonochem. 2009, 4, 386-399.
133. Hershko, A., Ciechanover, A., The ubiquitin system. Annu. Rev. Biochem. 1998, 67, 425-479.
134. Schwartz, A. L., Ciechanover, A., Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Annu. Rev. Pharmacol. Toxicol. 2009, 49, 73-96.
135. Schwartz, A. L., Ciechanover, A., Ubiquitin-mediated protein modification and degradation. Am. J. Respir. Cell. Mol. Biol. 1992, 7, 463-468.
136. Peng, J., Evaluation of proteomic strategies for analyzing ubiquitinated proteins. BMB Rep. 2008, 41, 177-183.
137. Hershko, A., The ubiquitin system for protein degradation and some of its roles in the control of the cell-division cycle (Nobel lecture). Angew. Chem. Int. Ed. Engl. 2005, 44, 5932-5943.
138. Peng, J., Schwartz, D., Elias, J. E., Thoreen, C. C., Cheng, D., Marsischky, G., Roelofs, J., Finley, D., Gygi, S. P., A proteomics approach to understanding protein ubiquitination. Nat. Biotechnol. 2003, 21, 921-926.
139. Maor, R., Jones, A., Nühse, T. S., Studholme, D. J. et al., Multidimensional protein identification technology (MudPIT) analysis of ubiquitinated proteins in plants. Mol. Cell. Proteomics 2007, 6, 601-610.
140. Kirkpatrick, D. S., Denison, C., Gygi, S. P., Weighing in on ubiquitin: the expanding role of mass-spectrometry-based proteomics. Nat. Cell. Biol. 2005, 7, 750-757.
141. Hitchcock, A. L., Auld, K., Gygi, S. P., Silver, P. A., A subset of membrane-associated proteins is ubiquitinated in response to mutations in the endoplasmic reticulum degradation machinery. Proc. Natl. Acad. Sci. USA 2003, 100, 12735-12740.
142. Jeon, H. B., Choi, E. S., Yoon, J. H., Hwang, J. H. et al., A proteomics approach to identify the ubiquitinated proteins in mouse heart. Biochem. Biophys. Res. Commun. 2007, 357, 731-736.
143. Layfield, R., Tooth, D., Landon, M., Dawson, S. et al., Purification of poly-ubiquitinated proteins by S5a-affinity chromatography. Proteomics 2001, 1, 773-777.
144. Hiyama, H., Yokoi, M., Masutani, C., Sugasawa, K. et al., Interaction of hHR23 with S5a. The ubiquitin-like domain of hHR23 mediates interaction with S5a subunit of 26 S proteasome. J. Biol. Chem. 1999, 274, 28019-28025.
145. Uchiki, T., Kim, H. T., Zhai, B., Gygi, S. P. et al., The ubiquitin-interacting motif protein, S5a, is ubiquitinated by all types of ubiquitin ligases by a mechanism different from typical substrate recognition. J. Biol. Chem. 2009, 284, 12622-12632.
146. Shimada, Y., Fukuda, T., Aoki, K., Yukawa, T. et al., A protocol for immunoaffinity separation of the accumulated ubiquitin-protein conjugates solubilized with sodium dodecyl sulfate. Anal. Biochem. 2008, 377, 77-82.
147. Tan, F., Lu, L., Cai, Y., Wang, J. et al., Proteomic analysis of ubiquitinated proteins in normal hepatocyte cell line Chang liver cells. Proteomics 2008, 8, 2885-2896.
148. Hjerpe, R., Aillet, F., Lopitz-Otsoa, F., Lang, V. et al., Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities. EMBO Rep. 2009, 10, 1250-1258.
149. Hartmann-Petersen, R., Hendil, K. B., Gordon, C., Ubiquitin binding proteins protect ubiquitin conjugates from disassembly. FEBS Lett. 2003, 535, 77-81.
150. Mayor, T., Deshaies, R. J., Two-step affinity purification of multiubiquitylated proteins from Saccharomyces cerevisiae. Methods Enzymol. 2005, 399, 385-392.
151. Bornhorst, J. A., Falke, J. J., Purification of proteins using polyhistidine affinity tags. Methods Enzymol. 2000, 326, 245-254.
152. Franco, M., Seyfried, N. T., Brand, A. H., Peng, J., Mayor, U., A novel strategy to isolate ubiquitin conjugates reveals wide role for ubiquitination during neural development. Mol. Cell. Proteomics 2011, 10, M110.002188.
153. Jitrapakdee, S., Wallace, J. C., The biotin enzyme family: Conserved structural motifs and domain rearrangements. Curr. Protein Pept. Sci. 2003, 4, 217-229.
154. Tagwerker, C., Flick, K., Cui, M., Guerrero, C. et al., A tandem affinity tag for two-step purification under fully denaturing conditions: application in ubiquitin profiling and protein complex identification combined with in vivocross-linking. Mol. Cell. Proteomics 2006, 5, 737-748.
155. Ventadour, S., Jarzaguet, M., Wing, S. S., Chambon, C. et al., A new method of purification of proteasome substrates reveals polyubiquitination of 20S proteasome subunits. J. Biol. Chem. 2007, 282, 5302-5309.
156. Thomas, S. N., Cripps, D., Yang, A. J., Proteomic analysis of protein phosphorylation and ubiquitination in Alzheimer's disease. Methods Mol. Biol. 2009, 566, 109-121.
157. Argenzio, E., Bange, T., Oldrini, B., Bianchi, F. et al., Proteomic snapshot of the EGF-induced ubiquitin network. Mol. Syst. Biol. 2011, 7, 462.
158. Medvedev, A. E., Clow, A., Sandler, M., Glover, V., Isatin - a link between natriuretic peptides and monoamines. Biochem. Pharmacol. 1996, 52, 385-391.
159. Medvedev, A., Igosheva, N., Crumeyrolle-Arias, M., Glover, V., Isatin: Role in stress and anxiety. Stress 2005, 8, 175-183.
160. Medvedev, A., Buneeva, O., Glover, V., Biological targets for isatin and its analogues: implications for therapy. Biol. Targets Therap. 2007, 1, 151-162.
161. Pandeya, S. N., Smitha, S., Jyoti, M., Sridhar, S. K., Biological activities of isatin and its derivatives. Acta Pharm. 2005, 55, 27-46.
162. Pang, F. Y., Hucklebridge, F. H., Forster, G., Tan, K., Clow, A., The relationship between isatin and monoamine oxidase-B inhibitory activity in urine. Stress Med. 1996, 12, 35-42.
163. Medvedev, A. E., Goodwin, B. L., Sandler, M., Glover, V., Efficacy of isatin analogues as antagonists of rat brain and heart atrial natriuretic peptide receptors coupled to particulate guanylyl cyclase. Biochem. Pharmacol. 1999, 57, 913-915.
164. Ivanov, Iu. D., Panova, N. G., Gnedenko, O. V., Bineeva, O. A. et al., Study of the tissue and subcellular distribution of isatin-binding proteins with optical biosensor. Vopr. Med. Khim. 2002, 48, 73-83.
165. Crumeyrolle-Arias, M., Buneeva, O., Zgoda, V., Kopylov, A. et al., Isatin binding proteins in rat brain: in situ imaging, quantitative characterization of specific [3H]isatin dinding, and proteomic profiling. J. Neurosci. Res. 2009, 87, 2763-2772.
166. Buneeva, O., Gnedenko, O., Zgoda, V., Kopylov, A. et al., Isatin binding proteins of rat and mouse brain: proteomic identification and optical biosensor validation. Proteomics 2010, 10, 23-37.
167. Medvedev, A., Buneeva, O., Gnedenko, V., Fedchenko, M. et al., Isatin interaction with glyceraldehyde-3-phosphate dehydrogenase, a putative target of neuroprotective drugs: partial agonism with deprenyl. J. Neural Transm. 2006, 71, 195-203.
168. Buneeva, O. A., Gnedenko, O. V., Medvedeva, M. V., Ivanov, Yu, D. et al., Interaction of pyruvate kinase with isatin and deprenyl. Biochem. (Moscow) Supp. Ser. B: Biomed. Chem. 2007, 1, 143-147.
169. Govorun, V. M., Archakov, A. I., Proteomic technologies in modern biomedical science. Biochemistry (Moscow) 2002, 67, 1109-1123.
170. Garbis, S., Lubec, G., Fountoulakis, M., Limitations of current proteomics technologies. J. Chromatogr. 2005, 1077, 1-18.
171. Butterfield, D. A., Perluigi, M., Sultana, R., Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics. Eur. J. Pharmacol. 2006, 545, 39-50.
172. Abel, E. L., Behavioral effects of isatin on open field activity and immobility in the forced swim test in rats. Physiol. Behav. 1995, 57, 611-613.
173. Bang, J. Y., Kim, E. Y., Kang, D. K., Chang, S. I. et al., Pharmaco-proteomic analysis of a novel cell-permeable peptide inhibitor of tumor-induced angiogenesis. Mol. Cell. Proteomics 2011, 10, M110.005264.
174. Rix, U., Superti-Furga, G., Target profiling of small molecules by chemical proteomics. Nat. Chem. Biol. 2009, 5, 616-624.
175. Righetti, P. G., Boschetti, E., The Proteominer and the Fortyniners: searching for gold nuggets in the proteomic arena. Mass Spectrom. Rev. 2008, 27, 596-608.
176. Righetti, P. G., Fasoli, E., Boschetti, E., Combinatorial peptide ligand libraries: the conquest of the "hidden proteome" advances at great strides. Electrophoresis 2011, 32, 960-966.
177. Beseme, O., Fertin, M., Drobecq, H., Amouyel, P., Pinet, F., Combinatorial peptide ligand library plasma treatment: advantages for accessing low abundance proteins. Electrophoresis 2010, 31, 2697-2704.
178. Boschetti, E., Bindschedler, L. V., Tang, C., Fasoli, E., Righetti, P. G., Combinatorial peptide ligand libraries and plant proteomics: a winning strategy at a price. J. Chromatogr. A 2009, 1216, 1215-1222.
179. Farinazzo, A., Restuccia, U., Bachi, A., Guerrier, L. et al., Chicken egg yolk cytoplasmic proteome, mined via combinatorial peptide ligand libraries. J. Chromatogr. A 2009, 1216, 1241-1252.
180. Fasoli, E., Sanz, L., Wagstaff, S., Harrison, R. A. et al., Exploring the venom proteome of the African puff adder, Bitis arietans, using a combinatorial peptide ligand library approach at different pHs. J. Proteomics 2010, 73, 932-942.
181. Meng, R., Gormley, M., Bhat, V. B., Rosenberg, A., Quong, A. A., Low abundance protein enrichment for discovery of candidate plasma protein biomarkers for early detection of breast cancer. J. Proteomics 2011, 75, 366-374.
182. Righetti, P. G., Boschetti, E., Fasoli, E., Capturing and amplifying impurities from recombinant therapeutic proteins via combinatorial peptide libraries: a proteomic approach. Curr. Pharm. Biotechnol. 2011, 12, 1537-1547.